Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Judge

Showing results (211-220 of 245) with videos related to

Pageof 25
Sort By:
BMC Pregnancy and Childbirth|August 15, 2022
The Tommy's Clinical Decision Tool, a device for reducing the clinical impact of placental dysfunction and preterm birth: protocol for a mixed-methods early implementation evaluation studyJenny Carter, Dilly Anumba, Lia Brigante, et al.
The Lancet. Healthy Longevity|July 13, 2023
Organisational factors associated with hospital costs and patient mortality in the 365 days following hip fracture in England and Wales (REDUCE): a record-linkage cohort studyPetra Baji, Rita Patel, Andrew Judge, et al.
Pilot and Feasibility Studies|February 26, 2026
Tommy's Clinical Decision Support Tool: an intervention development and feasibility study to inform a future randomised controlled trialJenny Carter, Dilly Anumba, Christy Burden, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2022
2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu ArteritisPeter C Grayson, Cristina Ponte, Ravi Suppiah, et al.
Annals of the Rheumatic Diseases|November 9, 2022
2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritisPeter C Grayson, Cristina Ponte, Ravi Suppiah, et al.
Age and Ageing|August 30, 2022
Multiple hospital organisational factors are associated with adverse patient outcomes post-hip fracture in England and Wales: the REDUCE record-linkage cohort studyRita Patel, Andrew Judge, Antony Johansen, et al.
BMC Musculoskeletal Disorders|February 12, 2009
Variations in the pre-operative status of patients coming to primary hip replacement for osteoarthritis in European orthopaedic centresPaul Dieppe, Andrew Judge, Susan Williams, et al.
Archives of Osteoporosis|June 3, 2020
Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, DenmarkM Sanni Ali, Martin Ernst, Danielle E Robinson, et al.
Archives of Osteoporosis|September 17, 2021
Correction to: Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, DenmarkM Sanni Ali, Martin Ernst, Danielle E Robinson, et al.
The Lancet. Rheumatology|September 3, 2021
Clinical and molecular associations with outcomes at 2 years after acute knee injury: a longitudinal study in the Knee Injury Cohort at the Kennedy (KICK)Cesar Garriga, Megan Goff, Erin Paterson, et al.
Pageof 25

Showing results (211-220 of 245) with videos related to

Sort By:
Pageof 25
BMC Pregnancy and Childbirth|August 15, 2022
The Tommy's Clinical Decision Tool, a device for reducing the clinical impact of placental dysfunction and preterm birth: protocol for a mixed-methods early implementation evaluation studyJenny Carter, Dilly Anumba, Lia Brigante, et al.
The Lancet. Healthy Longevity|July 13, 2023
Organisational factors associated with hospital costs and patient mortality in the 365 days following hip fracture in England and Wales (REDUCE): a record-linkage cohort studyPetra Baji, Rita Patel, Andrew Judge, et al.
Pilot and Feasibility Studies|February 26, 2026
Tommy's Clinical Decision Support Tool: an intervention development and feasibility study to inform a future randomised controlled trialJenny Carter, Dilly Anumba, Christy Burden, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 9, 2022
2022 American College of Rheumatology/EULAR Classification Criteria for Takayasu ArteritisPeter C Grayson, Cristina Ponte, Ravi Suppiah, et al.
Annals of the Rheumatic Diseases|November 9, 2022
2022 American College of Rheumatology/EULAR classification criteria for Takayasu arteritisPeter C Grayson, Cristina Ponte, Ravi Suppiah, et al.
Age and Ageing|August 30, 2022
Multiple hospital organisational factors are associated with adverse patient outcomes post-hip fracture in England and Wales: the REDUCE record-linkage cohort studyRita Patel, Andrew Judge, Antony Johansen, et al.
BMC Musculoskeletal Disorders|February 12, 2009
Variations in the pre-operative status of patients coming to primary hip replacement for osteoarthritis in European orthopaedic centresPaul Dieppe, Andrew Judge, Susan Williams, et al.
Archives of Osteoporosis|June 3, 2020
Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, DenmarkM Sanni Ali, Martin Ernst, Danielle E Robinson, et al.
Archives of Osteoporosis|September 17, 2021
Correction to: Alendronate use and bone mineral density gains in women with moderate-severe (stages 3B-5) chronic kidney disease: an open cohort multivariable and propensity score analysis from Funen, DenmarkM Sanni Ali, Martin Ernst, Danielle E Robinson, et al.
The Lancet. Rheumatology|September 3, 2021
Clinical and molecular associations with outcomes at 2 years after acute knee injury: a longitudinal study in the Knee Injury Cohort at the Kennedy (KICK)Cesar Garriga, Megan Goff, Erin Paterson, et al.
Pageof 25